VICRA M 12.5+500MG (Empagliflozin (12.5mg) + Metformin (500mg))

Vicra-M 12.5mg/500mg Tablet is a combination medication designed to assist in regulating blood glucose levels. It is intended for use alongside a balanced diet and consistent physical activity to enhance glycemic control in adults diagnosed with type 2 diabetes mellitus. This formulation aids in the effective utilization of insulin, which in turn facilitates the reduction of blood sugar concentrations. It is recommended to take the tablet with food at any time throughout the day, with an emphasis on consistency in timing each day. The prescribing physician will determine the appropriate dosage tailored to individual needs. It is imperative not to discontinue the medication abruptly without consulting a healthcare professional, as doing so could lead to an increase in blood sugar levels, potentially resulting in severe complications such as renal damage and vision loss. This medication should be considered a component of a comprehensive treatment regimen that includes dietary modifications, regular exercise, and weight management as directed by a healthcare provider. Individuals using this medication are advised to maintain adequate hydration to mitigate the risk of dehydration. Additionally, good personal hygiene practices may help prevent instances of fungal infections, particularly in the genital area, which some patients may experience. Prior to commencing this treatment, patients must inform their healthcare provider of any pre-existing kidney or liver conditions, urinary tract infections, or the use of diuretics. Pregnant and breastfeeding women should also seek medical advice before starting treatment. Regular monitoring of blood sugar levels is essential during the course of this medication.